Company Filing History:
2 out of 42 
1 out of 10 Years Active: 1998-2006
Title: The Innovations of Engler Heidrun: A Pioneer in Nucleic Acid Delivery
Introduction
Engler Heidrun is a prominent inventor based in San Diego, California, recognized for his groundbreaking contributions to the field of biotechnology. With two patents to his name, Heidrun has focused his research efforts on enhancing the delivery mechanisms of nucleic acids, particularly in the treatment of cancer. His innovative approaches have paved the way for advanced therapeutic applications in cellular biology.
Latest Patents
His latest inventions include advanced methodologies and formulations for nucleic acid delivery. One of his notable patents concentrates on enhancing the delivery of nucleic acids to cells through formulations that combine dextrin polymers with sugars. This combination not only optimizes the transportation of eucaryotic expression vectors but also demonstrates significant efficacy in vivo. Furthermore, Heidrun's work extends to cancer treatment, wherein he developed a method that utilizes a gene delivery system, such as a viral vector, formulated with delivery-enhancing agents like ethanol to improve therapeutic outcomes.
Career Highlights
Throughout his career, Engler Heidrun has showcased his inventive talents while working for notable companies such as Canji Inc. and Innovata Limited. His dedication and innovative spirit have established him as a significant figure in the biotechnology sector, striving to push the boundaries of medical treatments and therapies.
Collaborations
Collaborating with esteemed colleagues has been an integral part of Heidrun's journey. He has worked closely with professionals like Dan Maneval and Susan E. Conroy, who have contributed to his projects and helped refine his innovative ideas. Together, they have fostered an environment that encourages scientific exploration and collaboration.
Conclusion
Engler Heidrun stands out in the realm of biotechnology as an inventor whose work in nucleic acid delivery and cancer treatment is transforming therapeutic strategies. His continued focus on innovation and collaboration positions him as a key player in the advancement of medical science, promising a brighter future for various treatment modalities. The impact of his patents will likely resonate within the industry, inspiring future generations of inventors and researchers alike.